Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours

other OA: bronze public-domain-us
📄 Open PDF View on PubMed View at publisher

Abstract

The expression of five different antigens in ovarian tumours was studied by means of an immunohistochemical test with anti-CEA, HMFG1 and HMFG2, NS19-9 and OC125 antibodies. Considerable variation was noted not only between different histological types and between tumours of one type but also between areas in a single tumour. HMFG1 and HMFG2 were the most reactive of all the antibodies; NS19-9 and OC125 were expressed by different populations of cells. It is concluded that specific combinations of antibodies are more effective both for the monitoring of ovarian cancer as well as for immunodiagnosis and treatment, than any single one used.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antigens, Neoplasm Antigens, Surface Biomarkers, Tumor Carcinoembryonic Antigen Membrane Glycoproteins Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Antigens, Neoplasm Antigens, Surface Antigens, Tumor-Associated, Carbohydrate Biomarkers, Tumor Carcinoembryonic Antigen Cystadenocarcinoma Cystadenocarcinoma Cystadenoma Cystadenoma Endometriosis Endometriosis Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

SciLite annotations

organisms 1
human

Source provenance

europepmc
last seen: 2026-06-18T06:15:08.409253+00:00
pubmed
last seen: 2026-05-13T22:09:25.758913+00:00
scilite
last seen: 2026-05-18T04:25:29.313245+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine